electroCore, Inc. Current State and Local Tax Expense (Benefit)
electroCore, Inc. (ECOR) reported Current State and Local Tax Expense (Benefit) of -$21.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentStateAndLocalTaxExpenseBenefit · last filed 2026-03-19
- electroCore, Inc. current state and local tax expense (benefit) for fiscal 2025 was -$21.00K.
- electroCore, Inc. current state and local tax expense (benefit) for fiscal 2024 was -$116.00K.
- electroCore, Inc. current state and local tax expense (benefit) for fiscal 2023 was -$208.00K.
- electroCore, Inc. current state and local tax expense (benefit) for fiscal 2022 was -$449.00K.
| Period end | Current State and Local Tax Expense (Benefit) 12 month | Current State and Local Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$21.00K 10-K · filed 2026-03-19 | |
| 2024-12-31 | -$116.00K 10-K · filed 2026-03-19 | |
| 2023-12-31 | -$208.00K 10-K · filed 2025-03-12 | |
| 2022-12-31 | -$449.00K 10-K · filed 2024-03-13 | |
| 2021-12-31 | -$870.00K 10-K · filed 2023-03-08 | $870.32K 10-K · filed 2022-03-10 |
| 2020-12-31 | $1.17M 10-K · filed 2022-03-10 | -$1.17M 10-K · filed 2021-03-11 |
| 2019-12-31 | $7.71K 10-K · filed 2021-03-11 | |
| 2018-12-31 | $2.43K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |